Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 03/05/21 EST
64.85quote price arrow up+0.23 (+0.36%)
Volume
244,430
Close
64.62quote price arrow up+1.39 (+2.20%)
Volume
9,483,400
52 week range
56.56 - 85.97

...

Loading . . .

KEY STATS

  • Open63.42
  • Day High64.75
  • Day Low63.30
  • Prev Close63.23
  • 52 Week High85.97
  • 52 Week High Date03/19/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap81.201B
  • Shares Out1.257B
  • 10 Day Average Volume8.31M
  • Dividend2.84
  • Dividend Yield4.39%
  • Beta0.39
  • 1 Year % Change-19.45

RATIOS/PROFITABILITY

  • EPS (TTM)0.06
  • P/E (TTM)1,133.68
  • Fwd P/E (NTM)8.43
  • EBITDA (MRQ)5.56B
  • ROE (MRQ)0.60%
  • Revenue (MRQ)24.689B
  • Gross Margin (MRQ)81.48%
  • Net Margin (MRQ)0.36%
  • Debt To Equity (MRQ)172.52%

EVENTS

  • Earnings Date04/28/2021
  • Ex Div Date03/12/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

QUOTE FINDER

Profile

MORE
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Jyoti Mehra
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States